TransCode Therapeutics CEO Letter to Shareholders : comparem

BOSTON, July 05, 2023 -- Dear TransCode Therapeutics Shareholders, I want to express the optimism that permeates the management, board, and staff of TransCode as we navigate the ever-evolving...

Related Keywords

Boston , Massachusetts , United States , R Michael Dudley , Alan Freidman , Transcode Therapeutics Inc , University Of Texas Medical Center , Md Anderson Cancer Center , Globenewswire Inc , Dana Farber Cancer Center , Exchange Commission , Transcode Therapeutics Shareholders , Code Therapeutics , Farber Cancer Center , Cancer Center , Texas Medical Center , Orphan Drug Designation , Rare Pediatric Disease Designation , Priority Review Voucher , Rare Pediatric Disease Priority Review Voucher , Executive Officer , Private Securities Litigation Reform Act , Investigational New Drug , Annual Report ,